Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice

Experimental Dermatology

Volumn 24, Issue 6, 2015, Pages 436-442

  Kanemaru, Kaori ^a,b   Matsuyuki, Ayano ^a   Nakamura, Yoshikazu ^a,b   Fukami, Kiyoko ^a,b  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Animal model; Epidermal hyperplasia; Obesity; Psoriasis

Indexed keywords

ADIPONECTIN; BETA DEFENSIN 3; CD4 ANTIGEN; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 17C; INTERLEUKIN 22; INTERLEUKIN 23P19; INTERLEUKIN 36; LEPTIN; LORICRIN; MESSENGER RNA; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PROTEIN; PROTEIN KINASE B; REGENERATING ISLET DERIVED 3 GAMMA; RESISTIN; RETINOL BINDING PROTEIN 4; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; MEMBRANE PROTEIN; REG3G PROTEIN, MOUSE; TLR7 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 7;

ADIPOCYTE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; EAR SWELLING; ENZYME ACTIVATION; EPIDERMIS HYPERPLASIA; FEMALE; FOOD INTAKE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE CELL; KERATINOCYTE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKINFOLD THICKNESS; SWELLING; UPREGULATION; WESTERN BLOTTING; AGONISTS; ANIMAL; CELL LINE; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; EPIDERMIS; HYPERPLASIA; MALE; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY;

AMINOQUINOLINES; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; HUMANS; HYPERPLASIA; INTERLEUKIN-17; INTERLEUKINS; KERATINOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; OBESITY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEINS; PSORIASIS; TOLL-LIKE RECEPTOR 7;

EID: 84929514176     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12691     Document Type: Article

References (51)

1. Schon M P, Boehncke W H. N Engl J Med 2005: 352: 1899-1912.
2. Lande R, Gregorio J, Facchinetti V et al. Nature 2007: 449: 564-569.
3. Zheng Y, Danilenko D M, Valdez P et al. Nature 2007: 445: 648-651.
4. Albanesi C, De Pità O, Girolomoni G. Clin Dermatol 2007: 25: 581-588.
5. Gottlieb A B, Dann F. Am J Med 2009: 122: 1150.e1-1150.e9.
6. Naldi L, Chatenoud L, Linder D et al. J Invest Dermatol 2005: 125: 61-67.
7. Neimann A L, Shin D B, Wang X et al. J Am Acad Dermatol 2006: 55: 829-835.
8. Cohen A D, Sherf M, Vidavsky L et al. Dermatology 2008: 216: 152-155.
9. Naldi L, Addis A, Chimenti S et al. Dermatology 2008: 217: 365-373.
10. Yanaba K, Umezawa Y, Hayashi M et al. Arch Dermatol Res 2014: 306: 921-925.
11. Naldi L, Conti A, Cazzaniga S et al. Br J Dermatol 2014: 170: 634-642.
12. Jensen P, Zachariae C, Christensen R et al. JAMA Dermatol 2013: 149: 795-801.
13. Taylor K R, Costanzo A E, Jameson J M. J Invest Dermatol 2011: 131: 2409-2418.
14. Huang L, Li C. Cell Res 2000: 10: 81-92.
15. Van Belle A B, de Heusch M, Lemaire M M et al. J Immunol 2012: 188: 462-469.
16. Ma H L, Liang S, Naplerata L et al. J Clin Invest 2008: 118: 597-607.
17. van der Fits L, Mourits S, Voerman J S et al. J Immunol 2009: 182: 5836-5845.
18. Cai Y, Shen X, Ding C et al. Immunity 2011: 35: 596-610.
19. Di Cesare A, Di Meglio P, Nestle F O. J Invest Dermatol 2009: 129: 1339-1350.
20. Johansen C, Usher P A, Kjellerup R B et al. Br J Dermatol 2009: 160: 319-324.
21. Lowes M A, Russell C B, Martin D A et al. Trends Immunol 2013: 34: 174-181.
22. MacLeod A S, Hemmers S, Garijo O et al. J Clin Invest 2013: 123: 4364-4374.
23. Nakajima K, Kanda T, Takashi M et al. J Immunol 2011: 186: 4481-4489.
24. Chang S H, Reynolds J M, Pappu B P et al. Immunity 2011: 35: 611-621.
25. Song X, Zhu S, Shi P et al. Nat Immunol 2011: 12: 1151-1158.
26. Ramirez-Carrozzi V, Sambandam A, Luis E et al. Nat Immunol 2011: 12: 1159-1166.
27. Johnston A, Fritz Y, Dawes S M et al. J Immunol 2013: 190: 2252-2262.
28. Tortola L, Rosenwald E, Abel B et al. J Clin Invest 2012: 122: 3965-3976.
29. Lai Y, Li D, Li C et al. Immunity 2012: 37: 74-84.
30. Zheng Y, Valdez P A, Danilenko D M et al. Nat Med 2008: 14: 282-289.
31. Vaishnava S, Behrendt C L, Ismail A S et al. Proc Natl Acad Sci USA 2008: 105: 20858-20863.
32. Ghanaat-Pour H, Sjöholm Å. Metabolomics 2011: 1: 102.
33. Boden G. Endocrinol Metab Clin North Am 2008: 37: 635-646.
34. Boehncke S, Thaci D, Beschmann H et al. Br J Dermatol 2007: 157: 1249-1251.
35. Boehncke W H, Boehncke S, Tobin A M et al. Exp Dermatol 2011: 20: 303-307.
36. Guida B, Nino M, Perrino N R et al. J Eur Acad Dermatol Venereol 2010: 24: 191-195.
37. Peck Y, Ong P Y, Ohtake T et al. N Engl J Med 2002: 347: 1151-1160.
38. Fry L, Baker B S, Powles A V et al. Exp Dermatol 2014: doi: 10.1111/exd.12572, In Press.
39. Im E, Jung J, Rhee S H. J Interferon Cytokine Res 2012: 32: 583-591.
40. Shi H, Kokoeva M V, Inouye K et al. J Clin Invest 2006: 116: 3015-3025.
41. Kwan H Y, Fu X, Liu B et al. J Biol Chem 2014: 289: 30525-30537.
42. Ezure T, Amano S. J Invest Dermatol 2011: 131: 2004-2009.
43. Taylor K R, Mills R E, Costanzo A E et al. PLoS ONE 2010: 5: e11422.
44. Altavilla D, Saitta A, Cucinotta D et al. Diabetes 2001: 50: 667-674.
45. Heidenreich R, Röcken M, Ghoreschi K. Int J Exp Pathol 2009: 90: 232-248.
46. Gerdes S, Osadtschy S, Rostami-Yazdi M et al. Exp Dermatol 2012: 21: 43-47.
47. Gerdes S, Laudes M, Neumann K et al. Exp Dermatol 2014: 23: 438-440.
48. Ståhle M. Exp Dermatol 2015: 24: 181-182.
49. Cerman A A, Bozkurt S, Sav A et al. Br J Dermatol 2008: 159: 820-826.
50. Wang Y, Chen J, Zhao Y et al. Br J Dermatol 2008: 158: 1134-1135.
51. Xue K, Liu H, Jian Q et al. Exp Dermatol 2013: 22: 406-410.